Australian Government announces “patent box” scheme to boost medical and biotech innovation

Written By

rebecca currey module
Rebecca Currey

Partner
Australia

I am a partner in our Intellectual Property Group, based in Sydney. My experience spans the breadth and depth of IP issues, but my specialty is complex IP litigation and disputes including contentious patent, trade mark, copyright, and confidential information and consumer protection/passing-off matters.

patrick brown Module
Patrick Brown

Associate
UK

I am an Associate in our Intellectual Property Group in London, with a particular focus on the life sciences, pharmaceutical and chemical sectors.

The Australian Government has committed $206.4 million to a patent box tax incentive scheme to encourage investment in medical and biotechnology innovation.



Patent box schemes are a type of tax incentive where income from certain types of patents is taxed a preferential lower corporate tax rate. Australia will join over 20 other countries including the UK, France, China, Belgium and Switzerland in offering patent box type tax incentive schemes.

The scheme will come into effect from 1 July 2022 and will apply to granted patents that were filed after 11 May 2021. Although the details of the scheme are yet to be finalised, income derived solely from eligible…

Full article available on PatentHub

Latest insights

More Insights
featured image

Patent Litigation in Practice Series: Spotlight on Australia - Preliminary discovery in patent disputes

4 minutes May 29 2025

Read More
featured image

First UPC decision on Second Medical Use

2 minutes May 28 2025

Read More
featured image

Relocating production to a new supplier: Legal challenges in the supply chain (upstream and downstream)

3 minutes May 22 2025

Read More